Purdue Files Show It Knew Cuts Wouldn’t Kill OxyContin Sales

(Bloomberg) -- When Purdue Pharma LP cut the last of its sales force in June 2018, some analysts figured the move by the maker of OxyContin painkillers would help address a U.S. opioid-addiction ep...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.